Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

SFDA Publishes Report On Adverse Reactions Of Drugs

April 28, 2010
-
Health

China's State Food and Drug Administration has published a report on the adverse reactions to drug use.

As the first of its kind in China, the report is a summary of all the cases of adverse reactions that occurred in China in 2009. It shows that China received a total of 638,996 reports on the bad reactions to drug use in the year. Of these most were related to anti-infection drugs.

Most of the reports were said to have been made by medical institutions. Of these 86.7% were made on synthetic medicines and 13.3% on Chinese herbal medicines.

Of the total reports, 55.2% were made on anti-infection medicines, and this is followed by reports on medicines for cardiovascular disorders, which accounted for 7.6% of the reports.

Tags: allergy, drug, medicine, pharmaceutical, SFDA, TCM, traditional chinese medicine

Readers also read this:

Caterpillar China R&D Center Gets LEED Gold Certification

November 16, 2010

China Province To Eliminate Disposable Amenities From Hotels

November 5, 2010

Unilever China Wins China Green Gold Award

November 4, 2010

ZTE Organizes CSR Conference In Sanya

November 3, 2010

ADB And Tongji University Establish Urban Knowledge Hub

November 2, 2010

Yingli Green Energy Expands Production Capacity

November 1, 2010
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2022 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network